417 related articles for article (PubMed ID: 30677481)
1. A comparative study of polydopamine modified and conventional chemical synthesis method in doxorubicin liposomes form the aspect of tumor targeted therapy.
Bi D; Zhao L; Li H; Guo Y; Wang X; Han M
Int J Pharm; 2019 Mar; 559():76-85. PubMed ID: 30677481
[TBL] [Abstract][Full Text] [Related]
2. Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy.
Bi D; Zhao L; Yu R; Li H; Guo Y; Wang X; Han M
Drug Deliv; 2018 Nov; 25(1):564-575. PubMed ID: 29457518
[TBL] [Abstract][Full Text] [Related]
3. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
[TBL] [Abstract][Full Text] [Related]
4. Targeted antitumor comparison study between dopamine self-polymerization and traditional synthesis for nanoparticle surface modification in drug delivery.
Zhang M; Zou Y; Zuo C; Ao H; Guo Y; Wang X; Han M
Nanotechnology; 2021 May; 32(30):. PubMed ID: 33862617
[TBL] [Abstract][Full Text] [Related]
5. Mn
Xi J; Da L; Yang C; Chen R; Gao L; Fan L; Han J
Int J Nanomedicine; 2017; 12():3331-3345. PubMed ID: 28479854
[TBL] [Abstract][Full Text] [Related]
6. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
Moosavian SA; Abnous K; Badiee A; Jaafari MR
Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
[TBL] [Abstract][Full Text] [Related]
7. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
[TBL] [Abstract][Full Text] [Related]
8. Construction of Surface-Modified Polydopamine Nanoparticles for Sequential Drug Release and Combined Chemo-Photothermal Cancer Therapy.
Wei C; Wang P; Huang Z; He D; Zhu W; Liu H; Chen Z; Wang W; Li Y; Shen J; Qin L
Mol Pharm; 2021 Mar; 18(3):1327-1343. PubMed ID: 33530691
[TBL] [Abstract][Full Text] [Related]
9. TPGS-Galactose-Modified Polydopamine Co-delivery Nanoparticles of Nitric Oxide Donor and Doxorubicin for Targeted Chemo-Photothermal Therapy against Drug-Resistant Hepatocellular Carcinoma.
Du Z; Mao Y; Zhang P; Hu J; Fu J; You Q; Yin J
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35518-35532. PubMed ID: 34286569
[TBL] [Abstract][Full Text] [Related]
10. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
[TBL] [Abstract][Full Text] [Related]
11. Promotion of initial anti-tumor effect via polydopamine modified doxorubicin-loaded electrospun fibrous membranes.
Yuan Z; Zhao X; Wang X; Qiu W; Chen X; Zheng Q; Cui W
Int J Clin Exp Pathol; 2014; 7(9):5436-49. PubMed ID: 25337186
[TBL] [Abstract][Full Text] [Related]
12. Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy.
Wei Y; Gao L; Wang L; Shi L; Wei E; Zhou B; Zhou L; Ge B
Drug Deliv; 2017 Nov; 24(1):681-691. PubMed ID: 28414557
[TBL] [Abstract][Full Text] [Related]
13. The synthesis of LA-Fe
Chen Y; Zhang F; Wang Q; Lin H; Tong R; An N; Qu F
Dalton Trans; 2018 Feb; 47(7):2435-2443. PubMed ID: 29379913
[TBL] [Abstract][Full Text] [Related]
14. A novel high drug loading mussel-inspired polydopamine hybrid nanoparticle as a pH-sensitive vehicle for drug delivery.
Hou J; Guo C; Shi Y; Liu E; Dong W; Yu B; Liu S; Gong J
Int J Pharm; 2017 Nov; 533(1):73-83. PubMed ID: 28943209
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
[TBL] [Abstract][Full Text] [Related]
16. Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.
Yin X; Chi Y; Guo C; Feng S; Liu J; Sun K; Wu Z
Pharm Res; 2017 Oct; 34(10):2172-2184. PubMed ID: 28726003
[TBL] [Abstract][Full Text] [Related]
17. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo.
Qiu M; Sun H; Meng F; Cheng R; Zhang J; Deng C; Zhong Z
J Control Release; 2018 Feb; 272():107-113. PubMed ID: 29355618
[TBL] [Abstract][Full Text] [Related]
18. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
[TBL] [Abstract][Full Text] [Related]
19. Targeted H
Deng Z; Tang M; Zhao L; Long Y; Wen Z; Cheng Y; Zheng H
Colloids Surf B Biointerfaces; 2017 Dec; 160():207-214. PubMed ID: 28934664
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
